advertisement
Kolko M 313
Showing records 1 to 25 | Display only abstracts from Kolko M in IGR 21-4119799 Topical glaucoma medications - Possible implications on the meibomian glands
Fineide F
Acta Ophthalmologica 2024; 102: 735-748 (IGR: 25-1)
119896 Proteomic and Cytokine Profiling in Plasma from Patients with Normal-Tension Glaucoma and Ocular Hypertension
Langbøl M
Cellular and molecular neurobiology 2024; 44: 59 (IGR: 25-1)
122517 The Multifaceted Nongenetic Risk Factors for Primary Open-angle Glaucoma: An Overview of Systematic Reviews
Rovelt J
Ophthalmology. Glaucoma 2024; 0: (IGR: 25-1)
121901 Glaucoma: now and beyond
Jayaram H
Lancet 2023; 402: 1788-1801 (IGR: 25-1)
119799 Topical glaucoma medications - Possible implications on the meibomian glands
Magnø M
Acta Ophthalmologica 2024; 102: 735-748 (IGR: 25-1)
121901 Glaucoma: now and beyond
Kolko M
Lancet 2023; 402: 1788-1801 (IGR: 25-1)
119896 Proteomic and Cytokine Profiling in Plasma from Patients with Normal-Tension Glaucoma and Ocular Hypertension
Saruhanian A
Cellular and molecular neurobiology 2024; 44: 59 (IGR: 25-1)
122517 The Multifaceted Nongenetic Risk Factors for Primary Open-angle Glaucoma: An Overview of Systematic Reviews
Freiberg J; Azuara-Blanco A
Ophthalmology. Glaucoma 2024; 0: (IGR: 25-1)
119799 Topical glaucoma medications - Possible implications on the meibomian glands
Dahlø K
Acta Ophthalmologica 2024; 102: 735-748 (IGR: 25-1)
119896 Proteomic and Cytokine Profiling in Plasma from Patients with Normal-Tension Glaucoma and Ocular Hypertension
Saruhanian S
Cellular and molecular neurobiology 2024; 44: 59 (IGR: 25-1)
121901 Glaucoma: now and beyond
Friedman DS
Lancet 2023; 402: 1788-1801 (IGR: 25-1)
122517 The Multifaceted Nongenetic Risk Factors for Primary Open-angle Glaucoma: An Overview of Systematic Reviews
Virgili G
Ophthalmology. Glaucoma 2024; 0: (IGR: 25-1)
119896 Proteomic and Cytokine Profiling in Plasma from Patients with Normal-Tension Glaucoma and Ocular Hypertension
Tiedemann D
Cellular and molecular neurobiology 2024; 44: 59 (IGR: 25-1)
121901 Glaucoma: now and beyond
Gazzard G
Lancet 2023; 402: 1788-1801 (IGR: 25-1)
119799 Topical glaucoma medications - Possible implications on the meibomian glands
Kolko M
Acta Ophthalmologica 2024; 102: 735-748 (IGR: 25-1)
119896 Proteomic and Cytokine Profiling in Plasma from Patients with Normal-Tension Glaucoma and Ocular Hypertension
Baskaran T
Cellular and molecular neurobiology 2024; 44: 59 (IGR: 25-1)
122517 The Multifaceted Nongenetic Risk Factors for Primary Open-angle Glaucoma: An Overview of Systematic Reviews
Kolko M
Ophthalmology. Glaucoma 2024; 0: (IGR: 25-1)
119799 Topical glaucoma medications - Possible implications on the meibomian glands
Heegaard S; Vehof J
Acta Ophthalmologica 2024; 102: 735-748 (IGR: 25-1)
119896 Proteomic and Cytokine Profiling in Plasma from Patients with Normal-Tension Glaucoma and Ocular Hypertension
Vohra R; Rives AS
Cellular and molecular neurobiology 2024; 44: 59 (IGR: 25-1)
119799 Topical glaucoma medications - Possible implications on the meibomian glands
Utheim TP
Acta Ophthalmologica 2024; 102: 735-748 (IGR: 25-1)
119896 Proteomic and Cytokine Profiling in Plasma from Patients with Normal-Tension Glaucoma and Ocular Hypertension
Moreira J; Prokosch V; Liu H; Lackmann JW; Müller S; Nielsen CH; Kolko M; Rovelt J
Cellular and molecular neurobiology 2024; 44: 59 (IGR: 25-1)
117915 Predictors and long-term patterns of medication adherence to glaucoma treatment in Denmark-an observational registry study of 30 100 Danish patients with glaucoma
Kolko M
BMJ open ophthalmology 2024; 9: (IGR: 24-4)
117701 Steroids and/or Non-Steroidal Anti-Inflammatory Drugs as Postoperative Treatment after Trabeculectomy-12-Month Results of a Randomized Controlled Trial
Ahmadzadeh A
Journal of clinical medicine 2024; 13: (IGR: 24-4)
116853 Distinct Metabolic Profiles of Ocular Hypertensives in Response to Hypoxia
Langbøl M
International journal of molecular sciences 2023; 25: (IGR: 24-4)
117791 Association between Glucagon-like Peptide-1 Receptor Agonists and the Risk of Glaucoma in Individuals with Type 2 Diabetes
Niazi S
Ophthalmology 2024; 131: 1056-1063 (IGR: 24-4)
